Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.04
Delayed Data
As of Aug 16
 -0.01 / -0.49%
Today’s Change
1.81
Today|||52-Week Range
3.15
-1.45%
Year-to-Date

Today’s Trading

Previous close2.05
Today’s open2.08
Day’s range2.03 - 2.08
Volume592,509
Average volume (3 months)1,625,857
Market cap$326.4M
Dividend yield--
Data as of 08/16/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book2.67

Competitors

 Today’s
change
Today’s
% change
EDGEEdge Therapeutics In...-0.03-0.28%
AGENAgenus Inc-0.06-1.62%
SELBSelecta Biosciences ...+0.05+0.32%
BTXBioTime Inc-0.06-2.28%
Data as of 08/16/2017

Financials

Last reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts